The Best of ASCO Meetings offer timely science and education from the world’s premier oncology event, the ASCO Annual Meeting, in a two-day program. The abstracts chosen for presentation and discussion reflect the foremost research and strategies in oncology that will directly improve patient care. The program features in-depth discussion and analysis of the latest scientific findings in primary disease sites and practice-changing advances in cancer treatment. Expert faculty will place abstract findings into clinical context and discuss how the results may change the current standard of care. The Meetings’ smaller size allows for ample time for audience participation and attendee interaction.
Accreditation and Designation Statement
In support of improving patient care, the American Society of Clinical Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AMA Credit Designation Statement - Physicians
The American Society of Clinical Oncology designates this live activity for a maximum of 14.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA/NCCPA Credit Designation Statement – PAs
PAs may claim a maximum of 14.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
All non-physician attendees are welcome to submit a request for a Certificate of Participation, which may enable non-physicians to apply their meeting participation toward re-licensure. Please note, however, that all final decisions regarding certificate acceptance will be made by the licensing organization to which the certificate is submitted.
The Best of ASCO Meetings are designed for U.S. and international physicians and researchers involved in multidisciplinary clinical cancer care including, but not limited to, medical, surgical, and radiation oncologists; pathologists; radiologists; and other translational-oriented laboratory scientists.
The Best of ASCO Meetings are designed for the oncology team; credit is offered for physicians, but all are encouraged to participate as they may be able to apply for credit through their own licensing organization.
Educational Needs Statement
The Best of ASCO Meetings will continue the theme of the 54th ASCO Annual Meeting, “Delivering Discoveries: Expanding the Reach of Precision Medicine,” to discuss the increasing impact of precision medicine and expanding number of patients with cancer who could benefit from these new options for treatment. Precision medicine provides opportunities to move beyond personalized care and take into consideration each individual’s unique genetics, environment, and health status to diagnose their cancer and develop care plans. ASCO seeks to employ a diverse range of educational strategies to enable the implementation of precision medicine by the oncology care team, bolster clinical research, and support the sharing of best practices among its learners.
Upon participation in this activity, attendees will be able to
- Discuss the impact of precision medicine on the expanding population of cancer patients who can benefit from new advances in personalized care and treatment.
- Examine scientific advances that further enhance knowledge of cancer biology and treatment strategies;
- Incorporate knowledge of advances in precision medicine and clinical cancer research into care management strategies and clinical trial designs to improve patient outcomes;
- Evaluate the role of new diagnostic techniques and therapeutic approaches to the care and management of people with cancer;
- Effectively communicate with colleagues, members of the oncology care team, and with patients regarding recent advances in clinical cancer research; and
- Incorporate interprofessional and multi-disciplinary care coordination and training with all members of the oncology care team to provide the most effective treatment and supportive care plans for patients with cancer.
Disclaimer and Unlabeled Usage Statement
The information presented is that of the contributing faculty and presenters and does not necessarily represent the views of the Meeting Cosponsors and/or any named company or organization providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty or presenters. Therefore, before presenting any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions, and adverse effects.
ASCO and Conquer Cancer gratefully awknowledge the following companies for their support of the 2018 Best of ASCO Meeting: